155 related articles for article (PubMed ID: 28274596)
1. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.
Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.
Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z
Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647
[TBL] [Abstract][Full Text] [Related]
3. USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Peng J; Hu Q; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Wei W; Liu S; Wang H
Diagn Pathol; 2013 Oct; 8():177. PubMed ID: 24152793
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
5. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
[TBL] [Abstract][Full Text] [Related]
6. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
7. Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma.
Chen Y; Pang X; Ji L; Sun Y; Ji Y
Med Sci Monit; 2018 May; 24():3496-3505. PubMed ID: 29802710
[TBL] [Abstract][Full Text] [Related]
8. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma.
Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294
[TBL] [Abstract][Full Text] [Related]
9. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
12. USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1.
Kushwaha D; O'Leary C; Cron KR; Deraska P; Zhu K; D'Andrea AD; Kozono D
Cancer Biol Ther; 2015; 16(3):392-401. PubMed ID: 25692226
[TBL] [Abstract][Full Text] [Related]
13. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
Hu X; Huang Z; Liao Z; He C; Fang X
Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
[TBL] [Abstract][Full Text] [Related]
14. [Expression of USP9X in Non-small Cell Lung Cancer and Its Clinical Significance].
Peng J; Hu Q; Liu WP; Liu SL; Wang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):413-6. PubMed ID: 26121864
[TBL] [Abstract][Full Text] [Related]
15. Fibulin-1 functions as a prognostic factor in lung adenocarcinoma.
Cui Y; Liu J; Yin HB; Liu YF; Liu JH
Jpn J Clin Oncol; 2015 Sep; 45(9):854-9. PubMed ID: 26185140
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma.
Cui M; Yu W; Dong J; Chen J; Zhang X; Liu Y
Med Oncol; 2010 Sep; 27(3):632-9. PubMed ID: 19554484
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM
Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms.
Wolfsperger F; Hogh-Binder SA; Schittenhelm J; Psaras T; Ritter V; Bornes L; Huber SM; Jendrossek V; Rudner J
Cell Death Dis; 2016 Jan; 7(1):e2039. PubMed ID: 26775694
[TBL] [Abstract][Full Text] [Related]
19. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical implication of S100A12 in gastric carcinoma.
Li D; Zeng Z; Yu T; Qin J; Wu J; Song JC; Zhou ZY; Yuan JP
Tumour Biol; 2016 May; 37(5):6551-9. PubMed ID: 26638166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
